Development of an integrated end-to-end simulation platform for continuous manufacturing of oral tablets Ghent University
Despite manufacturing innovations and technologies on the rise, solid oral dosage in the pharmaceutical industry is still mass production. Although this is efficient and cost-effective, it is typically based on a ‘one-size-fits-all’ product concept and lacks the flexibility and agility required to fully meet the needs of the individual patient. Nowadays the pharmaceutical industry is experiencing a paradigm shift from batch to continuous ...